Cargando…
SAT182 Effects Of An Orally Bioavailable Nonpeptide Parathyroid Hormone Receptor Type 1 (PTH1R) Antagonist In Rodent Models Of Primary Hyperparathyroidism (PHPT)
Disclosure: A.S. Antwan: Employee; Self; Crinetics Pharmaceuticals. E. Rico-Bautista: Employee; Self; Crinetics Pharmaceuticals. J. Pontillo: Employee; Self; Crinetics Pharmaceuticals. S. Wang: Employee; Self; Crinetics Pharmaceuticals. M. Johns: Employee; Self; Crinetics Pharmaceuticals. B. Ramms:...
Autores principales: | Antwan, Agnes S, Rico-Bautista, Elizabeth, Pontillo, Joe, Wang, Shimiao, Johns, Michael, Ramms, Bastian, Fowler, Melissa A, Nguyen, Julie B, Castellanos Gonzalez, Anel A, Fleck, Beth, Retting, Kelsey, Dalvie, Deepak, Betz, Stephen F, Markison, Stacy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554536/ http://dx.doi.org/10.1210/jendso/bvad114.480 |
Ejemplares similares
-
LBSAT142 Discovery And Characterization Of A Potent And Orally Bioavailable Parathyroid Hormone Receptor Type-1 (PTHR1) Antagonist For The Treatment Of Hypercalcemia
por: Rico-Bautista, Elizabeth, et al.
Publicado: (2022) -
SAT-369 Parathyroid Microadenomas as a Cause of Normocalcemic Primary Hyperparathyroidism (PHPT) and a Surgical Challenge
por: Nguyen, Tiffany, et al.
Publicado: (2020) -
FRI687 Clinical Relevance Of 24-hour Urine Calcium Measurement In Patients With Primary Hyperparathyroidism (PHPT)
por: Bhan, Arti, et al.
Publicado: (2023) -
SAT-386 Inconsistent Bilateral Arm Serum PTH Testing in Recurrent Hyperparathyroidism in a Patient Status-Post Parathyroid Auto-Transplantation
por: Jenkins, Craig, et al.
Publicado: (2020) -
MON-532 Urinary Calcium Indices in Primary Hyperparathyroidism (PHPT) and Familial Hypocalciuric Hypercalcaemia (FHH): Is There a Need for Better Discrimination?
por: Arshad, Muhammad Fahad, et al.
Publicado: (2019)